Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PCDHB11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
C17orf82 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
XYLB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASPG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GIMAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060236 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDOA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERCC6L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAMP2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASEF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAZAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMZ2P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHX29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EYS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105370475 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRV1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on